末期腎臟病患者次發性副甲狀腺機能亢進之治療

Treatment of Secondary Hyperparathyroidism in Patients with End-Stage Kidney Disease

吳哲熊(Che-Hsiung Wu)

《腎臟與透析》 35卷3期 (2023/09) Pp. 123-127

https://doi.org/10.6340/KD.202309_35(3).0004

摘要

次發性副甲狀腺機能亢進為慢性腎病患者常見的併發症，可能引發腎性骨病變及心血管併發症。治療方式包括限磷飲食及使用磷離子結合劑治療高血磷、補充活性維生素D，與擬鈣劑藥物治療。若內科治療無效，可考慮副甲狀腺切除手術以治療頑固性副甲狀腺機能亢進。

關鍵字

慢性腎臟病 ； 副甲狀腺機能亢進 ； 擬鈣劑 ； 副甲狀腺切除

並列摘要

Secondary hyperparathyroidism, a common complication in patients with chronic kidney disease, can lead to renal osteodystrophy and cardiovascular complications. Treatment options include a low-phosphorus diet, the use of phosphate-binding agents to manage elevated blood phosphorus levels, supplementation of active vitamin D, and the administration of calcimimetic agents. If medical treatment proves ineffective, surgical removal of the parathyroid glands can be considered to address refractory secondary hyperparathyroidism.

並列關鍵字

chronic kidney disease ； secondary hyperparathyroidism ； calcimimetic agents ； parathyroidectomy